Zobrazeno 1 - 10
of 151
pro vyhledávání: '"Oleg I. Epstein"'
Publikováno v:
Dose-Response, Vol 20 (2022)
Background Nitric oxide (NO) as a vaso- and cardio-protective agent could reduce vasomotor dysfunction in different cardiovascular diseases. One of the current therapeutics targeted at NO availability in the vascular wall are highly diluted antibodie
Externí odkaz:
https://doaj.org/article/cf67d46ecce94d3e83647a37ed8896e0
Autor:
Vladimir T. Ivashkin, Elena A. Poluektova, Alexey B. Glazunov, Mikhail A. Putilovskiy, Oleg I. Epstein
Publikováno v:
BMC Gastroenterology, Vol 20, Iss 1, Pp 1-10 (2019)
Abstract Background The aim of this study was to investigate the efficacy and safety of the novel complex drug, consisting of released-active form of antibodies to S-100 protein, tumor necrosis factor-α and histamine, (Kolofort) under outpatient con
Externí odkaz:
https://doaj.org/article/eb8657622f934004b3b09fe527190a77
Autor:
Elena V. Kardash, Irina A. Ertuzun, Gul'nara R. Khakimova, Andrey N. Kolyadin, Sergey A. Tarasov, Stéphanie Wagner, Emile Andriambeloson, Vladimir T. Ivashkin, Oleg I. Epstein
Publikováno v:
Dose-Response, Vol 16 (2018)
Earlier studies have shown that combination of antibodies to S100 protein and to cannabinoid receptor type 1 in released-active form (Brizantin) may possess anxiolytic properties and decrease nicotine dependence. Released-active form of antibodies is
Externí odkaz:
https://doaj.org/article/1303268b0fbb448da6ee4e364c142c3a
Autor:
Sergeiy Korenev, Oleg I. Epstein, Vladimir Rafalskiy, Sergey A. Tarasov, Dmitry Pushkar, Natalia Gorelysheva, Mikhail Putilovskiy, Alexey B. Glazunov, Sergey Yakovlev, Ekaterina Moiseeva
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 21, Iss, Pp 188-194 (2020)
Background Urinary tract infections (UTIs) are among the most common bacterial infections in clinical practice. This RESOURCE (pathogen distribution and antibiotic RESistance prOfile of key Gram-negative bacteria caUsing community-onsEt URinary traCt
Autor:
K. S. Skrupskiy, A A Markov, R P Vasilevskiy, V V Soloviev, Yu A Kupriyanov, Rasner Pi, Oleg I. Epstein, A A Akrikidi, D Yu Pushkar, E V Nozdrin, I M Rokhlikov, Mikhail Putilovskiy, L A Logvinov
Publikováno v:
Urologiia. :36-42
Introduction Benign prostatic hyperplasia (BPH) is one of the most common diseases in men over 50 years. The prevalence of the BPH increases with age, and pathologic features of BPH are found in about 90% of men over 80 years. Aim The aim of the stud
Autor:
Gulnara Rinatovna Khakimova, Vladimir Anatolyevich Parfenov, Alexey I. Kochetkov, Victoria Vyacheslavovna Fateeva, Olga D. Ostroumova, T. M. Ostroumova, Oleg I. Epstein, Kristina Konstantinovna Khacheva
Publikováno v:
Neuropsychiatric Disease and Treatment. 15:1381-1402
Vascular cognitive impairment (VCI) and vascular dementia are the most common forms of cognitive disorder associated with cerebrovascular disease and related to increased morbidity and mortality among the older population. Growing evidence suggests t
Autor:
Elena S Gavrilova, Sergey A Bobrovnik, Gordon Sherriff, Andrey A Myslivets, Sergey A Tarasov, Oleg I Epstein
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e97017 (2014)
Selection of a suitable assay to measure the activity of drug agents based on release-active forms of anti-interferon-gamma antibodies (RA forms of Abs) is an important step forward in the investigation of such agents. In this study, the enzyme-linke
Externí odkaz:
https://doaj.org/article/9f3107c33dc440f88a8ae487a27bf9db
Publikováno v:
International Journal of Endocrinology, Vol 2013 (2013)
Purpose. To investigate the mechanism of action in peripheral tissues of novel complex drug containing release-active dilutions of antibodies to the beta subunit of the insulin receptor and antibodies to endothelial nitric oxide synthase (Subetta), w
Externí odkaz:
https://doaj.org/article/883a154d24fe4d4b97baeada8fe84936
Autor:
Sergey A. Tarasov, Reno J. Groenestein, Jean-Pierre Tafani, Oleg I. Epstein, Peter H. van der Meide, Naveena Yanamala, Elena Don, Evgeniy A. Gorbunov, A. Sylvia S. Schleker, Alexander L. Kovalchuk, Judith Klein-Seetharaman, Alexandra G. Emelyanova
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 205(5)
The therapeutic use of Abs in cancer, autoimmunity, transplantation, and other fields is among the major biopharmaceutical advances of the 20th century. Broader use of Ab-based drugs is constrained because of their high production costs and frequent
Autor:
Oleg I. Epstein, Sergey A. Tarasov, Ashot Mkrtumyan, Sergei Vorobiev, Mikhail Putilovskiy, Natalia Vorokhobina, Anna R. Volkova, Elena Andrianova, T I Romantsova
Publikováno v:
Diabetes Research and Clinical Practice. 142:1-9
Background To examine efficacy of Subetta as an add-on to insulin therapy in patients with type 1 diabetes mellitus (T1DM) a multicenter, double-blind, placebo-controlled, randomized clinical trial was performed. Derived by technological treatment of